Therasense Stock Fundamentals
| THER Stock | USD 0.0001 0.00 0.00% |
Therasense fundamentals help investors to digest information that contributes to Therasense's financial success or failures. It also enables traders to predict the movement of Therasense Pink Sheet. The fundamental analysis module provides a way to measure Therasense's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Therasense pink sheet.
Therasense |
Therasense Company Return On Asset Analysis
Therasense's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Therasense Return On Asset | -169.9 |
Most of Therasense's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Therasense is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Therasense has a Return On Asset of -169.9. This is much higher than that of the Healthcare sector and notably higher than that of the Biotechnology industry. The return on asset for all United States stocks is notably higher than that of the company.
Therasense Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Therasense's current stock value. Our valuation model uses many indicators to compare Therasense value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Therasense competition to find correlations between indicators driving Therasense's intrinsic value. More Info.Therasense is rated second in return on asset category among its peers. It is currently regarded number one company in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Therasense's earnings, one of the primary drivers of an investment's value.Therasense Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Therasense's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Therasense could also be used in its relative valuation, which is a method of valuing Therasense by comparing valuation metrics of similar companies.Therasense is currently under evaluation in return on asset category among its peers.
Therasense Fundamentals
| Return On Asset | -169.9 | |||
| Current Valuation | 27.3 M | |||
| Shares Outstanding | 6.15 B | |||
| Shares Owned By Insiders | 83.61 % | |||
| Number Of Shares Shorted | 199.92 K | |||
| Price To Book | 0.86 X | |||
| Price To Sales | 57.46 X | |||
| Revenue | 353.26 K | |||
| Gross Profit | 256.68 K | |||
| EBITDA | (5.53 M) | |||
| Net Income | (7.75 M) | |||
| Cash And Equivalents | 127.82 K | |||
| Total Debt | 2.9 M | |||
| Current Ratio | 0.22 X | |||
| Cash Flow From Operations | (5.54 M) | |||
| Short Ratio | 2.60 X | |||
| Earnings Per Share | (0) X | |||
| Number Of Employees | 16 | |||
| Beta | 22.12 | |||
| Market Capitalization | 20.3 M | |||
| Total Asset | 52 M | |||
| Retained Earnings | (248.68 M) | |||
| Working Capital | 6.84 M | |||
| Current Asset | 18.12 M | |||
| Current Liabilities | 11.29 M | |||
| Z Score | -1.4 |
About Therasense Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Therasense's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Therasense using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Therasense based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of novel cancer immunotherapy products. Theralink Technologies, Inc. was formerly known as OncBioMune Pharmaceuticals, Inc. and changed its name to Theralink Technologies, Inc. in September 2020. Theralink Technologies operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 16 people.
Additional Tools for Therasense Pink Sheet Analysis
When running Therasense's price analysis, check to measure Therasense's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Therasense is operating at the current time. Most of Therasense's value examination focuses on studying past and present price action to predict the probability of Therasense's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Therasense's price. Additionally, you may evaluate how the addition of Therasense to your portfolios can decrease your overall portfolio volatility.